We describe a simple method for preparing multimetallic nanoparticles by in situ decomposition of the corresponding Prussian blue analogue, which is adsorbed on carbon black. The example involves the AuNi(0.5)Fe core of the Pt(ML)/Au(1)Ni(0.5)Fe core-shell electrocatalyst for the oxygen reduction reaction. The core contains 3-5 surface atomic layers of Au, which play an essential role in determining the activity and stability of the catalyst. The Pt(ML)/AuNi(0.5)Fe electrocatalyst exhibited Pt mass and specific activities of 1.38 A/mg(Pt) and 1.12 × 10(-3) A/cm(2)(Pt), respectively, both of which are several times higher than those of commercial Pt/C catalysts. Its all-noble-metal mass activity (0.18 A/mg(Pt,Au)) is higher than or comparable to those of commercial samples. Stability tests showed an insignificant loss in activity after 15,000 triangular-potential cycles. We ascribe the high activity and stability of the Pt(ML)/AuNi(0.5)Fe electrocatalyst to its hierarchical structural properties, the Pt-core interaction, and the high electrochemical stability of the gold shell that precludes exposure to the electrolyte of the relatively active inner-core materials.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ja1063873 | DOI Listing |
Immunol Res
January 2025
Department of Genetics, Maharshi Dayanand University, Rohtak, Haryana, India.
In tropical countries, malaria transmission is the major health issue. To eradicate malaria, health communities depend on the control measure that affects economy and environment of the countries. To overcome these burdens, there is a great need to develop vaccine against malaria, but there is no vaccine to control malaria effectively.
View Article and Find Full Text PDFCommun Biol
January 2025
Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, TX, USA.
Aggregation of microtubule-associated tau protein is a distinct hallmark of several neurodegenerative disorders such as Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and progressive supranuclear palsy (PSP). Tau oligomers are suggested to be the primary neurotoxic species that initiate aggregation and propagate prion-like structures. Furthermore, different diseases are shown to have distinct structural characteristics of aggregated tau, denoted as polymorphs.
View Article and Find Full Text PDFBackground: Based on preclinical data showing addition of CDK4/6 inhibitors to gemcitabine was synergistic, ribociclib was evaluated in combination with gemcitabine to determine the maximum tolerated dose (MTD) and dose limiting toxicities (DLT).
Methods: In this single arm multicohort phase I trial, we evaluated the safety and efficacy of ribociclib plus gemcitabine in patients with advanced solid tumors. Patients received gemcitabine intravenously on days 1 and 8 followed by ribociclib days 8-14, with treatment repeated every 3 weeks.
Commun Biol
January 2025
Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Protein citrullination modification plays a pivotal role in the pathogenesis of rheumatoid arthritis (RA), and anti-citrullinated protein antibodies (ACPAs) are extensively employed for clinical diagnosis of RA. However, there remains limited understanding regarding specific citrullinated proteins and their implications in the progression of RA. In this study, we screen and verify insulin-like growth factor-2 mRNA binding protein 1 (IGF2BP1) as a novel citrullinated protein with significantly elevated citrullinated level in RA.
View Article and Find Full Text PDFNPJ Vaccines
January 2025
School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.
Cyclic peptides are often used as scaffolds for the multivalent presentation of drug molecules due to their structural stability and constrained conformation. We identified a cyclic deca-peptide incorporating lipoamino acids for delivering T helper and B cell epitopes against group A Streptococcus (GAS), eliciting robust humoral immune responses. In this study, we assessed the function-immunogenicity relationship of the multi-component vaccine candidate (referred to as VC-13) to elucidate a mechanism of action.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!